Massive Free Documents
Discover millions of professional documents covering academic, business, culture and more.
All Documents
Recently Uploaded
PDF
Beyond the Scan - Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe - Overcoming Systemic Barriers and Epidemiological Confounders
3
PDF
Migration-Informed Cancer Equity - A Global Perspective
2
PDF
Molecular and clinical characteristics of glioma patients with germline pathogenic mutations of Lynch syndrome genes - a largescale multicenter study
3
PDF
Financial toxicity and psychosocial distress of breast and cervical cancer patients at a tertiary healthcare facility in south-western Nigeria
2
PDF
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort
2
PDF
Systemic inflammatory ratios and their added value to cytology in cervical cancer detection - a multicenter study
2
PDF
ALDH + Anaplastic Thyroid Cancer Cells Show Vulnerability to a Pharmacologic Inducer of Centrosome Declustering
0
PDF
Diversity and Multi-Target Potential of Pyrazole, Imidazole or Triazole Derivatives in Modern Anticancer Therapy
2
PDF
Comparison of Stromal Tumor-Infiltrating Lymphocyte (sTIL) Levels and Clinicopathological Features in Neoadjuvant-Naive HER2-Low and HER2-Negative Primary Breast Cancers
1
PDF
Two Worlds, One Battle - How Bacteria and Malignancies Converge on Drug Resistance
2
PDF
Radon-Induced Radiation Biomarkers: A Scoping Review from Exposure Dosimetry to Early Biological Effects on the Lung - review
1
PDF
Prostate Cancer Biomarkers with a Focus on Galectin-3 - Emerging Clinical and Therapeutic Implications
1
PDF
Diagnostic Value of Serum CFL1 and TAGLN2 for Non-Metastatic Gastric Cancer - A Retrospective and Prospective Real-World Study
1
PDF
The Role of Oral Pathobionts' Outer Membrane Vesicles in Cancer Pathology and Therapeutic Development
3
PDF
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance postimmunotherapy
2
